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a b s t r a c t
Deﬁnite clinical diagnosis of microvascular angina is not possible with the existing knowl-
edge. Resting electrocardiogram may be normal, and exercise electrocardiogram may be
unremarkable. Echocardiography usually does not show regional wall motion abnormali-
ties. Transthoracic Doppler echocardiography can satisfactorily evaluate only left anterior
descending coronary artery and that too in some patients. Radio-isotope imaging can detect
only severe localized disease. Noninvasive diagnosis needs high index of suspicion. At
present, deﬁnite diagnosis is based on documentation of normal epicardial coronaries,
coronary ﬂow reserve less than 2.5 on adenosine induced hyperemia, and absence of spasm
of epicardial coronaries on acetylcholine provocation. Invasive evaluation is costly, needs
sophisticated equipments and expertise. Therapeutic and prognostic implications of various
parameters remains to be evaluated. At present invasive evaluation is recommended only
for patients with intractable symptoms with unconﬁrmed diagnosis, requiring repeated
hospitalization and evaluation with failure of empirical therapy.
# 2015 Cardiological Society of India. Published by Elsevier B.V. All rights reserved.
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journal homepage: www.elsevier.com/locate/ihjSigniﬁcant number of patients of angina have coronary
microvascular dysfunction alone or in combination with
stenosis and/or spasm of epicardial coronary arteries. Several
pathophysiology could be responsible. Common possibilities
are shown in Fig. 1. Diagnosis of microvascular dysfunction is
important because of therapeutic and prognostic implications.
1. Clinical proﬁle
1.1. Chronic stable angina
Microvascular angina can present as chronic stable angina.
With the available information, it is not possible to clinicallyE-mail address: sarweshwarm@gmail.com.
http://dx.doi.org/10.1016/j.ihj.2015.08.008
0019-4832/# 2015 Cardiological Society of India. Published by Elseviedifferentiate isolated microvascular angina from angina due to
isolated epicardial coronary artery disease.1,2 It is still more
difﬁcult to suspect component of microvascular dysfunction in
patients with established epicardial coronary artery disease.3
Persistence of symptoms after successful intervention/surgery
can be a clue. Symptoms disproportionate to angiographic
ﬁndings can be another clue. Absence of quick and/or sufﬁcient
relief with nitroglycerine or after cessation of effort has been
suggested as another clue. However, patients with critical
stenosis of epicardial coronaries especially those with triple
vessel disease may also respond slowly. Comparative evalua-
tion of documented cases of isolated epicardial coronary artery
stenosis versus those with documented isolated microvascular
dysfunction may give some clue to speciﬁc clinical features.r B.V. All rights reserved.
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Fig. 1 – Pathophysiology of microvascular angina.
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It is felt that coronary microvascular dysfunction can present
as rest angina/acute coronary syndrome.1 Clinical differentia-
tion from epicardial coronary artery disease is difﬁcult. Some
clues have been suggested in literature. Patients with
microvascular coronary spasm have been shown to have
symptoms more frequently at rest, more often at night and in
early morning.5 Ong et al.6 observed that compared with
patients of primary epicardial spasm, patients with microvas-
cular spasm presented more frequently with ischemic ECG
changes during noninvasive testing, exertional dyspnea, and
intermittent rest angina in addition to effort angina. Kaski
et al.7 observed that distinct from patients with Prinzmetal's
angina, ST segment elevation is extremely rare in patients
with microvascular angina. Kanatsuka et al.4 observed that
nitroglycerine may not provide quick and/or sufﬁcient chest
pain control compared with Prinzmetal's angina. Persistence
of effort angina despite full control of coronary spasm with
vasodilatory therapy also suggests combination of variant and
microvascular angina.8 Esophageal motility disorder is fre-
quent comorbidity in patients with syndrome X.9 Differentia-
tion may be challenging. Concomitant effort breathlessness
and changes in resting and stress ECG support possibility of
microvascular angina. Most of these studies have however,
evaluated patients of syndrome X rather than cases of
documented microvascular angina. Further, the observed
differences are only relative. Deﬁnite clinical diagnosis of
coronary microvascular dysfunction as a cause of rest angina/
acute coronary syndrome is difﬁcult. Evaluation of larger
number of well documented cases is needed.
Cardiac syndrome Y (named because of possible causal
role of neuropeptide Y) also presents as rest angina.
Hemodynamically, it is characterized by an abnormally high
microvascular resistance at rest but a normal vasodilatoryresponse to direct vasodilators and pacing.10 Pain may worsen
with nitroglycerine if there is signiﬁcant fall in aortic
perfusion pressure. Angiographically, it presents as coronary
slow ﬂow.11 It may be transient and ECG stress test response is
usually normal.
1.3. Angina equivalents
Patients with ‘‘angina equivalent’’ symptoms have not been
evaluated in any study. This area needs to be explored.
Similarly patients with atypical chest pain have not been
evaluated for microvascular dysfunction. Atypical presenta-
tion of angina is seen more frequently in women, diabetics,
and elderly. These group of patients are also more likely to
have coronary microvascular dysfunction. Some of the
patients, who are initially diagnosed to have ‘‘nonischemic’’
discomfort develop classical ischemic syndrome in following
few months. It is possible that some of these cases initially
have microvascular dysfunction.
1.4. ST elevation myocardial infarction
It is thought that coronary microvascular dysfunction can
cause ST elevation myocardial infarction.1 It is, however,
possible that these patients had transient thrombosis followed
by microembolization. This could result in myocardial infarc-
tion with normal coronary angiogram and microvascular
dysfunction. Release of vasoconstrictor molecules and reper-
fusion injury could also contribute to coronary microvascular
dysfunction. It is also possible that myocardial infarction
occurred because of transient epicardial coronary artery
spasm and subsequently detected coronary microvascular
dysfunction was not the actual culprit. Actual role of
microvascular dysfunction in ST elevation myocardial infarc-
tion is not clear.12
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syndrome/Takatsubo cardiomyopathy)
Coronary microvascular dysfunction is considered to be
involved in genesis of stress-induced cardiomyopathy.13
However, possibility of epicardial coronary spasm as the
initial event cannot be excluded by subsequent demonstration
of dysfunction and recovery in microvascular function in the
affected area. Ischemia itself can also increase microvascular
resistance.14 Further, such abnormality is not observed in all
cases.15 This hypothesis also cannot explain almost exclusive
occurrence in postmenopausal females, occurrence after acute
physical stress in some patients, and almost exclusive
localization to left ventricular apex in most cases. Prospective
studies recruiting subjects with localized microvascular
dysfunction and documenting subsequent occurrence of
stress cardiomyopathy in the same areas on follow-up can
prove etiological relation.
1.6. Chronic diastolic and/or systolic failure
Chronic, diffuse, persistent, and progressive coronary micro-
vascular dysfunction can produce global diastolic and/or
systolic dysfunction with normal coronary angiogram. Super-
ﬁcially these cases will resemble idiopathic dilated cardiomy-
opathy. Coronary microvascular dysfunction has been
observed in cases of idiopathic dilated cardiomyopathy.16
Cause/effect relationship remains to be explored.
2. Noninvasive evaluation
2.1. Resting ECG
There is no literature on any speciﬁc diagnostic feature in
resting electrocardiogram. Resting electrocardiogram may not
show ST segment depression even during chest pain epi-
sodes.17 Ohba et al.5 have observed that patients with
microvascular coronary spasm were likely to have minor
borderline ischemic electrocardiogram ﬁndings at rest.
2.2. Echocardiography
It has been suggested that chest pain and ischemia like
electrocardiographic changes without any wall motion abnor-
mality on echocardiography can suggest microvascular angi-
na.1 However, ischemia was not documented in all these cases.
Adenosine and dobutamine can themselves also produce
chest pain and ST segment changes. Adenosine has been
shown to provoke diastolic dysfunction in cases of microvas-
cular angina.18 Chronic coronary microembolism has also
been shown to produce diastolic dysfunction in conscious
dogs.19 However, impact of acute embolization in the territory
of a coronary artery may not correctly reﬂect the effect of
chronic microvascular dysfunction which is non-uniformly
distributed across the microvascular bed20 rather than
conﬁned to territory of a large epicardial coronary artery.
Microvascular dysfunction may not produce echocardiogra-
phically detectable dysfunction even during stress test despite
the occurrence of angina, dyspnea, ECC changes, andperfusion abnormalities.21,22 This has been explained to be
due to normally functioning adjacent myocardium. Transient
functional disturbance of coronary microvasculature may also
escape detection on echocardiography done when the patient
is asymptomatic. There can be signiﬁcant inter-observer
variability in interpretation of mild localized hypokinesia.
Correlation of site, etiology, extent, and severity of coronary
microvascular dysfunction with echocardiographic parame-
ters is not known. Tissue Doppler imaging may detect early
long axis diastolic dysfunction in patients with diffuse disease.
Adenosine may induce such an abnormality not present on
baseline examination.18 Strain rate imaging with speckle
tracking may identify focal diastolic and/or systolic dysfunc-
tion. Diffuse involvement may produce diffuse diastolic and or
systolic dysfunction.
2.3. Exercise ECG
No speciﬁc features have been identiﬁed in treadmill stress
test response. Exercise ECG is usually unremarkable.1 Negative
treadmill stress test dose not exclude possibility of intermit-
tent coronary microvascular dysfunction. Patients with coro-
nary microvascular spasm and 'cardiac syndrome Y' usually
have normal treadmill stress test. It has been observed that
angina may not occur even with positive exercise testing. Such
a response can be related to impaired cortical processing of
neural pain stimuli in patients with microvascular angina.23 It
has been suggested that slow recovery or unsatisfactory
response to sublingual nitrates may suggest component of
microvascular dysfunction.24 Earlier appearance of ECG
abnormalities and/or angina during an exercise test performed
after sublingual nitrate is also considered to suggest coronary
microvascular dysfunction. Comparison of treadmill stress
test response of patients with isolated epicardial coronary
stenosis with those with documented isolated microvascular
dysfunction may give some clue.
2.4. Transthoracic Doppler echocardiography25
Flow in left anterior descending coronary artery can be
evaluated by transthoracic Doppler echocardiography. Coro-
nary ﬂow velocity is measured at baseline and again after
adenosine induced maximal hyperemia. Difference is taken as
representative of coronary ﬂow reserve (CFR). In absence of
epicardial coronary artery disease, increased ﬂow is taken as
an indirect marker of dilatation of coronary microvasculature
in response to adenosine. This method has some limitations.
(i) Coronary angiography is needed to exclude epicardial
coronary artery disease. (ii) Procedure requires high frequency
transducer (7–12 MHz) and highly sensitive and dedicated
equipment. (iii) It is signiﬁcantly dependent on acoustic
window. (iv) Usually only left anterior descending coronary
artery is accessible for evaluation. Satisfactory assessment of
other coronary arteries is either not possible or needs
signiﬁcant angle correction. Even in the left anterior descend-
ing coronary artery only mid to distal segment can be
evaluated. Dysfunction in the region of branches proximal
to the site of sample volume is not evaluated. (v) Only
signiﬁcant difference in coronary ﬂow velocity can be
appreciated. Mild coronary microvascular dysfunction is likely
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coronary ﬂow. Failure of signiﬁcant increase in ﬂow is likely
only, if most of the branches distal to the site of sample volume
are signiﬁcantly diseased. Microvascular dysfunction can be
patchy and heterogeneous.20 Involvement of only some distal
vessels may not affect overall impact of adenosine, resulting in
false negative response. Compensatory vasodilatation of
unaffected distal branches may also contribute to false
negative result. (vii) This method evaluates response only to
systemic vasodilators. It cannot evaluate resting tone of
microcirculation. Further, evaluation of response to vasocon-
strictors needs additional invasive procedure.
2.5. Other noninvasive investigations
2.5.1. Contrast stress echocardiography
This modality can detect coronary microvascular dysfunction
if signiﬁcant territory of a coronary artery or a major branch is
signiﬁcantly diseased. Patchy involvement is likely to be
missed. Diffuse mild involvement across the myocardium may
also fail to produce an area of localized relative diminution in
contrast. Studies are needed to deﬁne the diagnostic role in
cases of microvascular angina.
2.5.2. Stress thallium 201 uptake
It may not reveal localized area of reduced uptake in patients
with diffuse mild involvement. Rosano et al.26 have observed
relative overall reduction in thallium uptake and reduced
washout in their patients with syndrome X compared to
control. Overall sensitivity of the test for detecting coronary
microvascular dysfunction is low.
2.5.3. 99 Tc-sestamibi imaging
It gives better image quality as compared to thallium.
However, lower net extraction by myocardium and greater
hepatic and gastrointestinal uptake interfere with proper
interpretation of defects specially along the inferior wall.27
Perfusion defects are seen in less than 50% patients of syndrome
X.28,29 Diagnostic signiﬁcance of positive scan is also not clear.
Fragasso et al. performed dobutamine stress echocardiography
on 22 patients of syndrome X with stress-induced perfusion
defects documented by 99m-Tc-MIBI scintigraphy. Only 12
patients showed wall motion abnormality. In 5 out of 12, the
location of dobutamine induced wall motion abnormality did
not coincide with site of perfusion defect.30
2.5.4. Cardiovascular magnetic resonance
Adenosine induced reversible subendocardial perfusion
defects in presence of normal coronary angiogram can be
suggestive of coronary microvascular dysfunction. However,
results of previous studies have been controversial.31 Further,
the test has low speciﬁcity, as signiﬁcant percentage of
patients with subendocardial defects have been shown to
have epicardial coronary spasm on intracoronary acetylcho-
line testing.32 Relatively low resolution, high cost, and scare
availability also prevent routine use.
2.5.5. Nuclear magnetic resonance spectroscopy33
It can detect ischemia due to coronary microvascular
dysfunction. However, high cost and scare availabilityprevent routine use. Further, it can explore only anterior
myocardium.
Noninvasive tests cannot differentiate between epicardial
and microvascular disease and lack sensitivity and speciﬁcity
for the diagnosis of coronary vasomotor dysfunction.34
3. Invasive evaluation
3.1. Documentation of normal or near normal epicardial
coronary arteries
For considering diagnosis of primary microvascular angina, it
is necessary to document that epicardial coronary arteries are
normal not only in structure but also in function. Normal
coronary angiogram does not exclude diffuse atherosclerosis
with abnormal epicardial resistance35 and atherosclerosis
with positive remodeling. Intravascular ultrasound frequently
reveals coronary atherosclerosis in patients with normal
coronary angiograms.36 Such epicardial coronary arteries
cannot be considered ‘‘normal’’ or ‘‘near normal’’ because
even early atherosclerosis produces endothelial dysfunction.5
Endothelial dysfunction even without signiﬁcant luminal
obstruction also carries adverse prognosis. Even intravascular
ultrasound cannot exclude such abnormalities in branches of
coronary arteries because of practical difﬁculty in manipulat-
ing the transducer in branches. Calciﬁcation of epicardial
coronaries may also occur without signiﬁcant luminal ob-
struction. Such vessels are also likely to have decreased
vasodilatation on demand. Normal coronary angiogram also
does not exclude possibility of transient thrombosis or spasm
of epicardial coronaries. Increased tendency for vasospasm at
the site of nonobstructive plaque is well established2 and can
contribute to angina in patients with ‘‘near normal’’ coronary
angiogram.
Acetylcholine and adenosine respectively cause endo-
thelium dependent and endothelium independent vasodi-
latation of epicardial coronaries. Normal response to these
pharmacological agents does not exclude abnormal re-
sponse of epicardial coronaries to other stimuli of day-to-
day life, e.g. physical or emotional stress. Therefore,
epicardial coronaries cannot be considered functionally
normal only on the ground of normal response to pharma-
cological stress.
3.2. Documentation that a lesion in epicardial coronary
artery is non ﬂow limiting
Microvascular dysfunction frequently coexists with epicardial
coronary artery disease. Microvascular dysfunction can be
considered only of epicardial lesion is non-ﬂow limiting.
At present, fractional ﬂow reserve (FFR) is used to assess
functional signiﬁcance of a coronary lesion. FFR is measured
as ratio of distal coronary pressure to aortic pressure recorded
by pressure pullback recording during maximal hyperemia.37
Value of less than 0.75 is considered to suggest a ﬂow limiting
lesion. There may be discordance between FFR and angio-
graphic ﬁndings.38 This is frequent with intermediate steno-
sis specially osteal lesions. Measurement of FFR is also
affected by microcirculatory response to adenosine.39
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and misleadingly high FFR. On the other hand an exaggerated
dilatory response of microcirculation may cause non ﬂow
limiting lesions to have low FFR due unusually high hyper-
emic ﬂow rate. Following measures can be helpful in case of
mismatch.
- Hyperemic stenosis resistance index (HSRI)39
It is calculated as hyperemic pressure gradient across a
lesion divided by average peak velocity at hyperemia. It
requires a dual sensor (Pressure and Doppler Velocity) guide
wire. Normal reference value is 0. Value of >0.8 is the
threshold for prediction of ischemia. As HSRI incorporates
both pressure and ﬂow in the same index it has been shown
to be superior to FFR in identifying ﬂow limiting lesson.
- Hemodynamic of a nearby reference vessel without focal
epicardial disease39
Although microvascular dysfunction can be heteroge-
neously distributed across the coronary vascular bed, low
value of CFR in a nearby reference vessel strongly suggests
diffuse microvascular disease.
3.3. Evaluation of coronary microvascular function
3.3.1. Slow coronary ﬂow
In absence of epicardial coronary artery disease, rate of runoff of
contrast from coronary arteries gives rough impression of rate of
ﬂow through microcirculation. Corrected thrombolysis in
myocardial infarction (TIMI) frame count is also used for
quantitative assessment of coronary blood ﬂow.40 Slow coro-
nary ﬂow is likely to be present only when there is microvascular
dysfunction involving major portion of a coronary artery. It is,
therefore, likely to represent diffuse involvement of microvas-
culature and may be positive only in advanced stage of
disease.41 It can also occur due to diffuse spasm or increased
basal coronary vascular tone. Slow ﬂow conﬁned to one
coronary artery can also be due to transient thrombosis
followed by thrombolysis and microembolization. Persistence
of slow ﬂow is likely to be due to some structural alteration.41
3.3.2. Myocardial blush
Myocardial opaciﬁcation during coronary angiography allows
an approximate visualization of microcirculation.42 However,
it is subjective and has low sensitivity.
3.3.3. Detection of increased metabolic markers of ischemia in
coronary sinus
Results of previous studies have been controversial even in
patients with ischemic appearing ST segment depression
during stress tests.43 It has been hypothesized that release of
ischemic metabolites by the small ischemic foci may remain
undetected because of their dilution in the larger ﬂow from
normally perfused myocardium. However, most of these
studies have been performed on patients of syndrome X
rather than cases documented to have coronary microvascular
dysfunction. Studies of documented cases with analysis of
blood in the respective cardiac vein can give correct impres-
sion. Invasive nature and technical difﬁculties preclude
routine use.3.3.4. Measurement of CFR
It is measured as ratio of coronary ﬂow at maximal dilation to
ﬂow at baseline measured by a Doppler ﬂow wire. Value of less
than 2.5 is considered abnormal.37 It interrogates ﬂow in
epicardial coronary as well as microcirculation, Therefore, it
cannot be used for evaluation of coronary microvascular
function in presence of lesions in epicardial coronaries. It also
has several other limitations including dependence on
baseline blood ﬂow, lower reproducibility, and technical
problems.
3.3.5. Calculation of index of microcirculatory resistance (IMR)
A coronary pressure wire is placed in distal coronary artery to
measure distal coronary pressure. Using a speciﬁc software,
the same wire tip is used as distal thermistor, while the shaft of
the wire serves as a proximal thermistor. Mean transit time of
room temperature saline injected down the coronary artery is
derived from coronary thermodilution curve. IMR is calculated
as distal coronary pressure multiplied by the hyperemic mean
transit time. Using this method in an animal model, Fearon
et al.44 concluded that IMR increased after disruption of
microcirculation with embolized microspheres and the
change was independent of the status of epicardial coronary
artery. There are some limitations in transpolating these
conclusions to humans.
(1) Application in patients with concomitant stenosis of
epicardial coronaries
Epicardial stenosis created by an occluder does not truly
represent pathology of coronary artery disease in humans.
In humans the lesions can affect different or multiple sites,
can have several morphologies and different severity.
Further, epicardial coronaries of patients of syndrome X
have been shown to have diffuse atherosclerosis and
endothelial dysfunction.35
In presence of ﬂow limiting epicardial stenosis, the
distal coronary artery is likely to have less adenosine and,
therefore less vasodilatation than the segment proximal
to obstruction. This will affect the gradient, ﬂow rate,
transit time, and distal pressure. In the study of Fearon
et al.44 also IMR was higher ( p < 0.03) after epicardial
stenosis.
In humans, signiﬁcant epicardial coronary stenosis is
usually associated with recruitment of collaterals. Signiﬁ-
cant collateral circulation is likely to affect the distal
pressure, gradient, and transit time. It results in overesti-
mation of IMR.45 Collaterals arising from proximal segment
of the same vessel may signiﬁcantly reduce pressure
proximal to obstruction and resultant gradient.
Fearon et al.44 applied the occluder on left anterior
descending coronary artery before any branch. It can be
considered equivalent to osteal stenosis. In humans,
stenosis may be after major proximal branches. Adenosine
induced dilatation of these branches and resulting 'steal
phenomenon' is likely to affect the gradient and calcula-
tion of IMR.
In view of above-mentioned limitations, it is clear that
IMR may not be reliable in presence of signiﬁcant stenosis
of epicardial coronary artery. It remains a challenge to be
solved.
Table 1 – Causes of angina or angina like discomfort with
normal coronary angiogram.
1. Coronary microvascular dysfunction
2. Epicardial coronary artery dysfunction
(a) Diffuse atherosclerosis
(b) Endothelial dysfunction
(c) Spasm
(d) Thrombosis followed by
thrombolysis
3. Increased myocardial oxygen demand
(a) Systemic hypertension, aortic valve
disease.
Left ventricular hypertrophy
(b) Pulmonary hypertension,
pulmonary valve
disease. Right ventricular
hypertrophy
4. Myocardial diseases
(a) Myocarditis
(b) Dilated cardiomyopathy
(c) Inﬁltrative disorders
(d) Myocyte disorders
5. Systemic disorders
(a) Anemia
(b) Thyrotoxicosis
6. Non anginal discomforts
(a) Exercise induced bronchospasm
(b) Esophageal motility disorders,
hiatus hernia
(c) Abnormal pain perception
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dysfunction
Fearon et al.44 used microsphere embolization for
disrupting the microcirculation. This may correlate only
with acute microembolization that follows thrombolytic
therapy or coronary intervention. In humans there are
several other chronic/intermittent, structural and/or func-
tional alterations that produce coronary microvascular
dysfunction.46
Microembolization produces non-homogeneous in-
volvement of microcirculation. Some micro-vessels are
likely to receive more emboli and others are likely to
receive less or no emboli. This is expected to result
in inhomogeneous distribution of adenosine in
different vessels. Dilatation of nonobstructed vessels is
likely to produce 'steal phenomenon' and affect distal
pressure.
Calculation of IMR is based on the assumption that at
peak hyperemia, the variability of vascular tone and
hemodynamic will be eliminated and the minimum
microvascular resistance will be achieved. This assump-
tion does not consider inter-individual variability in the
effect of adenosine. Failure to achieve maximum hyper-
emia may result in overestimation of IMR.45 Intracoronary
injection of adenosine or nicorandil has been shown to be
more effective.47
It is therefore, clear that results of microembolization in
animal studies may not apply to coronary microvascular
dysfunction in humans.
(3) Other limitations in use of IMR
Distance the sensor is placed down a vessel is an
important determinant of the mean transit time. Variabili-
ty of IMR depending on the distance of the wire down the
vessel needs evaluation.45 It is important because it may
not be possible to keep the sensor in the 'distal third' of the
vessel in each patient specially when the distal part is
hypoplastic. When the distal one third of the vessel is small
in caliber, the sensing wire may have some occluding
effect.
Most of the studies have been performed on left anterior
descending coronary artery which is a relatively straight
vessel. Left circumﬂex and right coronary artery have
angulations and large branches in middle one third.
Studies are needed to ﬁnd if calculation of IMR will be
equally applicable to these vessels.
3.3.6. Coronary microvasculatory spasm provocation test
In patients with history suggestive of vasospastic angina,
coronary vasospasm is precipitated by intracoronary injec-
tion of acetylcholine. Appearance of angina and ECG
changes without spasm of epicardial coronary artery
suggests coronary microvascular spasm. However, coronary
microvascular spasm frequently coexists with spasm of
epicardial coronaries.48 Diagnosis of coronary microvascular
spasm is difﬁcult in such cases. Further, absence of
epicardial coronary spasm during pharmacological stress
does not exclude possibility of vasospastic angina during
stresses of day-to-day life, e.g. cold presser or mental stress.
It is also important that coronary spasm may be occurring invessel other than the artery being evaluated. Right coronary
artery is most susceptible to vasospasm. Therefore, assess-
ment of coronary microvascular function only in left
anterior descending coronary may be insufﬁcient. Pharma-
cological provocation of coronary spasm also has some risk
of arrhythmias.
4. Other issues that need consideration
(i) Most of the data have been developed from patients of
syndrome X rather than from patients documented to
have microvascular dysfunction.49 Now, we know that
there are many causes for chest pain with normal
coronary angiogram (Table 1). Future studies should
enroll patients documented to have coronary microvas-
cular dysfunction.
(ii) None of the methods can evaluate microcirculatory
dysfunction in the territory of the branches proximal to
the site of interrogation. Microcirculatory dysfunction
localized to the territory of the proximal branches is
likely to be missed producing false negative results. It is
important because microcirculatory dysfunction may be
heterogeneous among different portions of coronary
circulation.
(iii) These methods do not evaluate resting tone of microcir-
culation. Increased resting tone can reduce ﬂow through
coronary microcirculation.
(iv) These methods evaluate vasomotor response to acetyl-
choline and adenosine. Positive as well as negative result
to these pharmacological agents may not truly represent
Classical Unstable angina Angina Va sospasc angina
stable angina              ACS wi th diagnosc                        equivalen ts                      with diagnosc ST 
ECG  elevaon
TMT                                                            TMT
Posive                                                              Po sive
CAG CAG                                            CAG      CAG
Normal Normal Normal CAD Normal
FFR ACH provocaon
> 85% < 85%      Angina+  ST elevation
No spasm of 
epicardial  coronaries
IMR
Increased
Microv ascula r anginaMic rovascula r angina
Fig. 2 – Diagnostic algorithm. Abbreviations: Ach, acetylcholine; ACS, acute coronary syndrome; CAD, coronary artery disease;
CAG, coronary angiography; IMR, index of microcirculatory resistance; FFR, fractional flow reserve; TMT, treadmill stress test.
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false negative results.
(v) These tests evaluate functional disturbance of microcir-
culation. Response in patients with structural defects of
microcirculation may be different.
(vi) Normal range of values of various criteria for evaluating
coronary microvascular function need to be deﬁned in
- Population of different age, sex, and ethnic background
without coronary risk factors. These variables can
affect coronary vasodilatory reserve.50,51
- Different coronary arteries and their branches.52
Deﬁning ‘‘norms’’ in different subsets of population is
necessary to detect early subclinical microvascular
dysfunction. Identiﬁcation at subclinical stage will help
in developing strategies to retard progression or even
attempt reversal of the disease process. Deﬁning norms
in all branches is necessary because microvascular
dysfunction may be localized to one part of microvascu-
lature.
(vii) Most of the studies have evaluated effect of various
pharmacological agents on dilatory capacity of
microcirculation. Some persons could have normal
vasodilatation but abnormal vasoconstriction. Normal
range of vasoconstrictory response to different
stress (e.g. cold presser, mental stress) needs to be
explored.
(viii) Data are also needed to ﬁnd impact of various factors that
may inﬂuence the normal range of the parameters of
microcirculatory function e.g.
- Body mass index.- Left ventricular mass index.
- Diameter of epicardial coronaries.
- Endothelium dependent and endothelium indepen-
dent function of epicardial coronary arteries.
- Positive remodeling of epicardial coronaries.
- Coronary calciﬁcation
- Coronary risk factors53
(ix) Inter-individual variability in response to different types
of stress and different doses of same pharmacological
agents need evaluation.54
(x) Therapeutic and prognostic signiﬁcance of results of
various tests needs evaluation.
(xi) Diagnosis in asymptomatic stage of disease needs
evaluation.
Because of varied etio-patho-physiology, different clinical
presentations and scare availability of invasive evaluation, a
simple algorhythmic approach is not possible. However, a
simple algorithm for clinical working is presented in Fig. 2.
5. Conclusion
Microvascular dysfunction is more frequent than appreciated.
It may be a primary pathology or may coexist with stenosis
and/or spasm of epicardial coronary arteries. Diagnosis is
likely to affect management and prognosis. Clinical differen-
tiation from epicardial coronary artery disease is not possible
at present. Noninvasive imaging with echocardiography and
nuclear perfusion are not sufﬁciently sensitive. At present the
diagnosis is based on combination of normal coronary
i n d i a n h e a r t j o u r n a l 6 7 ( 2 0 1 5 ) 5 5 2 – 5 6 0 559angiogram, absence of epicardial coronary spasm during
acetylcholine infusion and coronary ﬂow reserve less than
2.5 on adenosine induced hyperemia. However, each compo-
nent of diagnostic criteria has some limitations. Purely
dichomatous interpretation of data derived from invasive
evaluation should be avoided.39 Clinical proﬁle and results of
all investigations should be correlated. It is also important that
coronary microvascular dysfunction can be intermittent and
cannot be excluded dogmatically if symptoms or laboratory
ﬁndings do not develop with any given challenge at a given
time. However one should also be careful to avoid over
diagnosis. There is need to develop a cheap, effective, safe, and
widely available noninvasive test for detection of coronary
microvascular dysfunction.
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